Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

delta-Opioid receptor: the third extracellular loop determines naltrindole selectivity

X Li1, E V Varga, D Stropova

  • 1Department of Pharmacology, College of Medicine, University of Arizona, Tucson 85724, USA.

European Journal of Pharmacology
|April 4, 1996
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intrathecal PKA-selective siRNA treatment blocks sustained morphine-mediated pain sensitization and antinociceptive tolerance in rats.

Journal of neuroscience methods·2011
Same author

Sustained morphine-mediated pain sensitization and antinociceptive tolerance are blocked by intrathecal treatment with Raf-1-selective siRNA.

British journal of pharmacology·2010
Same author

The interaction of a benzodiazepine receptor antagonist (Ro15-1788) with GABA and GABA receptor antagonists at the GABA(A) receptor chloride-ionophore complex.

Neurochemistry international·2010
Same author

Functional selectivity in cannabinoid signaling.

Current molecular pharmacology·2009
Same author

Different levels of gamma-synuclein mRNA in the cerebral cortex of dominant, neutral and submissive rats selected in the competition test.

Genes, brain, and behavior·2005
Same author

Central GABAergic systems and depressive illness.

Neurochemical research·2003

Researchers created human opioid receptor chimeras to study ligand selectivity. Modifying the third extracellular loop altered naltrindole binding, suggesting distinct receptor domains for different opioid ligands.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Neuroscience

Background:

  • Opioid receptors are crucial targets for pain management and addiction therapies.
  • Understanding ligand selectivity is key to developing safer and more effective analgesics.
  • Extracellular loops of opioid receptors are implicated in ligand binding and receptor activation.

Purpose of the Study:

  • To investigate the role of the second and third extracellular loops in the selectivity of alkaloid ligands for delta-opioid receptors and mu-opioid receptors.
  • To determine how specific structural domains within opioid receptors contribute to differential ligand binding.

Main Methods:

  • Construction of human delta/mu-opioid receptor chimeras by exchanging extracellular loop domains.
  • Assessment of ligand binding affinities for the chimeric receptors using radioligand binding assays.

Related Experiment Videos

  • Comparative analysis of naltrindole and morphine affinity for wild-type and chimeric receptors.

    • Main Results:

    • Exchanging the third extracellular loop of the delta-opioid receptor with that of the mu-opioid receptor significantly reduced naltrindole affinity.
    • This modification did not substantially affect the binding affinity of morphine.
    • The findings indicate domain-specific interactions between opioid receptors and alkaloid ligands.

    Conclusions:

    • Different extracellular domains of opioid receptors are critical for the selective binding of distinct alkaloid ligands.
    • The third extracellular loop plays a key role in determining naltrindole selectivity at the delta-opioid receptor.
    • These insights can inform the design of novel opioid-based therapeutics with improved selectivity profiles.